CK

Chinannai Khanita Suman

Active Director Director DIN 11748740
DIN 11748740 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Chinannai Khanita Suman

Data last updated:

Chinannai Khanita Suman is a Director at Womy Foods And Nutraceuticals Private Limited (since 2026) and Director at Edomics Academy Private Limited (since 2026).

DIN 11748740
Primary Designation Director
First Appointment 30 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jun 20262026Active
Edomics Academy Private Limited U72100TN2026PTC193789
Director30 May 20262026Active

Board colleagues of Chinannai Khanita Suman

Directorship timeline

Open interactive timeline →
Edomics Academy Private Limited
Womy Foods And Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Chinannai Khanita Suman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chinannai Khanita Suman

Chinannai Khanita Suman currently holds 2 directorships: Womy Foods And Nutraceuticals Private Limited (Director, since 26 Jun 2026); Edomics Academy Private Limited (Director, since 30 May 2026).

Chinannai Khanita Suman was first appointed on 30 May 2026 as Director at Edomics Academy Private Limited.

The current boards of Chinannai Khanita Suman's companies include Madar Inamul Hasan (Womy Foods And Nutraceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available